Skip to main content
. 2022 Jul;23(7):2279–2284. doi: 10.31557/APJCP.2022.23.7.2279

Table 2.

EAU Risk Groups and Pathologic Stages of Each Group

Overall
n (%)
213 (100)
Adjuvant treatment
n (%)
159 (74.6)
No adjuvant treatment
n (%)
54 (25.4)
P value
EAU risk groups
Low+Intermediate-risk 33 (15.49) 21 (9.85) 12 (5.64)
High-risk 180 (84.51) 138 (64.79) 42 (19.72) 0.114
Pathologic stage
T2 14 (6.57) 8 (3.75) 6 (2.82)
T3a 54 (25.35) 37 (17.37) 17 (7.98)
T3b 145 (68.07) 114 (53.52) 31 (14.55) 0.103